Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Georgiev

Showing results (221-230 of 232) with videos related to

Pageof 24
Sort By:
Cell Reports|April 27, 2017
Quantification of the Impact of the HIV-1-Glycan Shield on Antibody ElicitationTongqing Zhou, Nicole A Doria-Rose, Cheng Cheng, et al.
Journal of Virology|August 22, 2014
Enhanced potency of a broadly neutralizing HIV-1 antibody in vitro improves protection against lentiviral infection in vivoRebecca S Rudicell, Young Do Kwon, Sung-Youl Ko, et al.
Science Immunology|August 8, 2017
Potent and broad HIV-neutralizing antibodies in memory B cells and plasmaLaTonya D Williams, Gilad Ofek, Sebastian Schätzle, et al.
Journal of Virology|November 10, 2025
Glycan-reactive antibodies isolated from human HIV-1 vaccine trial participants show broad pathogen cross-reactivityParker J Jamieson, Xiaoying Shen, Alexandra A Abu-Shmais, et al.
Nature Medicine|November 13, 2023
Dynamics and durability of HIV-1 neutralization are determined by viral replicationPhilipp Schommers, Dae Sung Kim, Maike Schlotz, et al.
Nature|March 5, 2014
Developmental pathway for potent V1V2-directed HIV-neutralizing antibodiesNicole A Doria-Rose, Chaim A Schramm, Jason Gorman, et al.
Cell|March 8, 2016
Maturation Pathway from Germline to Broad HIV-1 Neutralizer of a CD4-Mimic AntibodyMattia Bonsignori, Tongqing Zhou, Zizhang Sheng, et al.
Nature Medicine|June 6, 2018
Epitope-based vaccine design yields fusion peptide-directed antibodies that neutralize diverse strains of HIV-1Kai Xu, Priyamvada Acharya, Rui Kong, et al.
Cell|May 26, 2015
Structural Repertoire of HIV-1-Neutralizing Antibodies Targeting the CD4 Supersite in 14 DonorsTongqing Zhou, Rebecca M Lynch, Lei Chen, et al.
Nature Medicine|February 5, 2020
Potent Zika and dengue cross-neutralizing antibodies induced by Zika vaccination in a dengue-experienced donorVincent Dussupt, Rajeshwer S Sankhala, Gregory D Gromowski, et al.
Pageof 24

Showing results (221-230 of 232) with videos related to

Sort By:
Pageof 24
Cell Reports|April 27, 2017
Quantification of the Impact of the HIV-1-Glycan Shield on Antibody ElicitationTongqing Zhou, Nicole A Doria-Rose, Cheng Cheng, et al.
Journal of Virology|August 22, 2014
Enhanced potency of a broadly neutralizing HIV-1 antibody in vitro improves protection against lentiviral infection in vivoRebecca S Rudicell, Young Do Kwon, Sung-Youl Ko, et al.
Science Immunology|August 8, 2017
Potent and broad HIV-neutralizing antibodies in memory B cells and plasmaLaTonya D Williams, Gilad Ofek, Sebastian Schätzle, et al.
Journal of Virology|November 10, 2025
Glycan-reactive antibodies isolated from human HIV-1 vaccine trial participants show broad pathogen cross-reactivityParker J Jamieson, Xiaoying Shen, Alexandra A Abu-Shmais, et al.
Nature Medicine|November 13, 2023
Dynamics and durability of HIV-1 neutralization are determined by viral replicationPhilipp Schommers, Dae Sung Kim, Maike Schlotz, et al.
Nature|March 5, 2014
Developmental pathway for potent V1V2-directed HIV-neutralizing antibodiesNicole A Doria-Rose, Chaim A Schramm, Jason Gorman, et al.
Cell|March 8, 2016
Maturation Pathway from Germline to Broad HIV-1 Neutralizer of a CD4-Mimic AntibodyMattia Bonsignori, Tongqing Zhou, Zizhang Sheng, et al.
Nature Medicine|June 6, 2018
Epitope-based vaccine design yields fusion peptide-directed antibodies that neutralize diverse strains of HIV-1Kai Xu, Priyamvada Acharya, Rui Kong, et al.
Cell|May 26, 2015
Structural Repertoire of HIV-1-Neutralizing Antibodies Targeting the CD4 Supersite in 14 DonorsTongqing Zhou, Rebecca M Lynch, Lei Chen, et al.
Nature Medicine|February 5, 2020
Potent Zika and dengue cross-neutralizing antibodies induced by Zika vaccination in a dengue-experienced donorVincent Dussupt, Rajeshwer S Sankhala, Gregory D Gromowski, et al.
Pageof 24